STEP AWAY....MY GUESS WE'RE GOING TO 3-4 CENTS.
Recent ALLR News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2024 12:00:34 PM
- Allarity Therapeutics Strengthens Leadership with Key Appointments to Accelerate Stenoparib PARP Inhibitor Program • GlobeNewswire Inc. • 10/03/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/01/2024 09:34:12 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/01/2024 09:32:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 12:00:32 PM
- Allarity Therapeutics Announces Two Patients Now Exceeding One Year of Treatment with Stenoparib in Advanced Ovarian Cancer Trial • GlobeNewswire Inc. • 09/16/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2024 12:53:18 PM
- Allarity Therapeutics Announces New CFO and Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 09/13/2024 12:45:00 PM
- Allarity Therapeutics Takes Decisive Step Toward Regaining Nasdaq Compliance with Nasdaq Listing Rule 5550(a)(2) • GlobeNewswire Inc. • 09/11/2024 12:00:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/10/2024 01:15:59 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/09/2024 08:05:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 01:00:09 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/30/2024 08:05:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2024 08:55:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/05/2024 09:24:15 PM
- Allarity Therapeutics Announces Postponement of Annual Stockholders Meeting • GlobeNewswire Inc. • 07/26/2024 01:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 07/26/2024 10:04:13 AM
- Allarity Encourages Shareholders to Vote FOR the Reverse Stock Split and Decrease in Authorized Shares • GlobeNewswire Inc. • 07/24/2024 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 08:05:17 PM
- Allarity Therapeutics Outlines Company’s 2024 Progress and Objectives • GlobeNewswire Inc. • 07/22/2024 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/22/2024 10:03:17 AM
- Allarity Granted Hearing Before Nasdaq Panel to Present Plan of Regaining Compliance • GlobeNewswire Inc. • 06/27/2024 12:00:00 PM
- Allarity Therapeutics’ Dual PARP/Tankyrase Inhibitor, Stenoparib, Continues to Show Extended Clinical Benefit in Advanced Ovarian Cancer • GlobeNewswire Inc. • 06/25/2024 12:00:00 PM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM